TY - JOUR
T1 - Weight loss and malnutrition in patients with chronic graft-versus-host disease
AU - Jacobsohn, D. A.
AU - Margolis, J.
AU - Doherty, J.
AU - Anders, V.
AU - Vogelsang, G. B.
PY - 2002
Y1 - 2002
N2 - It is well known that weight loss occurs in patients with chronic graft-versus-host disease. However, the severity and frequency of weight loss in this population have not been adequately described. Recent data suggest that a body-mass index (BMI) below 21.9 is an independent risk factor for mortality. In our analysis we have shown that out of 93 patients with cGVHD, 43% are malnourished as evidenced by a BMI less than 21.9 and 14% are severely malnourished (BMI less than 18.5). In addition, there is a clear trend showing that patients with active, ongoing cGVHD have lower BMIs (P = 0.02). Furthermore, we show that many symptoms thought to contribute to weight loss in patients with cGVHD, such as odynophagia and oral sensitivity, are not related to weight loss in our population. We conclude that, in all likelihood, unknown causes still exist that are responsible for weight loss in this group of patients. Elevated resting energy expenditure and elevated serum tumor necrosis factor-α are potential contributors to weight loss that will be tested in future studies. We also conclude that treating cGVHD aggressively may help reverse weight loss and malnutrition, which may be independent risk factors for mortality in this population.
AB - It is well known that weight loss occurs in patients with chronic graft-versus-host disease. However, the severity and frequency of weight loss in this population have not been adequately described. Recent data suggest that a body-mass index (BMI) below 21.9 is an independent risk factor for mortality. In our analysis we have shown that out of 93 patients with cGVHD, 43% are malnourished as evidenced by a BMI less than 21.9 and 14% are severely malnourished (BMI less than 18.5). In addition, there is a clear trend showing that patients with active, ongoing cGVHD have lower BMIs (P = 0.02). Furthermore, we show that many symptoms thought to contribute to weight loss in patients with cGVHD, such as odynophagia and oral sensitivity, are not related to weight loss in our population. We conclude that, in all likelihood, unknown causes still exist that are responsible for weight loss in this group of patients. Elevated resting energy expenditure and elevated serum tumor necrosis factor-α are potential contributors to weight loss that will be tested in future studies. We also conclude that treating cGVHD aggressively may help reverse weight loss and malnutrition, which may be independent risk factors for mortality in this population.
KW - Chronic graft-versus-host disease
KW - Hematopoietic stem cell transplantation
KW - Malnutrition
KW - Weight loss
UR - http://www.scopus.com/inward/record.url?scp=0036184585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036184585&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1703352
DO - 10.1038/sj.bmt.1703352
M3 - Article
C2 - 11859395
AN - SCOPUS:0036184585
SN - 0268-3369
VL - 29
SP - 231
EP - 236
JO - Bone marrow transplantation
JF - Bone marrow transplantation
IS - 3
ER -